LiP-MS, A Machine Learning-based Chemoproteomic Approach to Identify Drug Targets in Complex Proteomes - Biognosys

LiP-MS, A Machine Learning-based Chemoproteomic Approach to Identify Drug Targets in Complex Proteomes

Seminar Recordings

Video Recording of Minisymposium #21 at AACR 2021

Presenter: Nigel Beaton
A collaboration with:  AstraZeneca, ETH Zurich

Minisymposium session April 11, 3:35 PM US EDT: MS.CH01.01 – Cancer Proteomics and Screening Technologies

Abstract

 

Back to Resources overview

Helpdesk

Access our knowledge base with relevant resources and guiding information.

Contact

    Close banner

    New: Drug Target Validation

    Reveal Binding Sites with Structural Proteomics

    New: Drug Target Validation

    Reveal Compound Binding Sites with Structural Proteomics

    Learn More